The roPROTix platform: Creating a digital to physical continuum for efficient multi-targeting drug discovery
The roPROTix platform: Creating a digital to physical continuum for efficient multi-targeting drug discovery
At Perspix Biotech, we are shifting the paradigm of multi-targeting drug discovery by connecting “digital design” and “physical” experimentation workflows into a closed-loop-feedback-system.
Machine Learning
AI-powered In
silico design
Format agnostic
Robotics
Automated high
speed production
25k parallel
Tailored Modalities
Multi-dimensional
characterization
Optimized molecules
Data Analytics
Mining of large
datasets
Interrelated
Our roPROTix platform automatically generates tens of thousands of in-silico designed modalities of any kind (e.g. multi-specific antibodies) and directly analyzes them simultaneously for key functional and biophysical properties.
This end-to-end process generates interrelated multidimensional datasets of unprecedented quantity and quality, which feed directly into our machine learning algorithms that drive the in-silico design engine.
The combination of roPROTix ultra-high-throughput “physical” production and screening with advanced digital design approaches allows to create a high number of multi-targeting molecules tailored to meet key parameters for successful transition into technical and clinical development at an accelerated pace.
At Perspix Biotech, we are shifting the paradigm of multi-targeting drug discovery by connecting “digital design” and “physical” experimentation workflows into a closed-loop-feedback-system.
Machine Learning
AI-powered In silico design
Format agnostic
Robotics
Automated high speed production
25k parallel
Tailored Modalities
Multi-dimensional characterization
Optimized molecules
Data Analytics
Mining of large datasets
Interrelated
Our roPROTix platform automatically generates tens of thousands of in-silico designed modalities of any kind (e.g. multi-specific antibodies) and directly analyzes them simultaneously for key functional and biophysical properties.
This end-to-end process generates interrelated multidimensional datasets of unprecedented quantity and quality, which feed directly into our machine learning algorithms that drive the in-silico design engine.
The combination of roPROTix ultra-high-throughput “physical” production and screening with advanced digital design approaches allows to create a high number of multi-targeting molecules tailored to meet key parameters for successful transition into technical and clinical development at an accelerated pace.
Now it is time for change
Copyright 2022 Perspix Biotech | All rights reserved
Copyright 2022 Perspix Biotech | All rights reserved